Insider Selling: Alignment Healthcare, Inc. (NASDAQ:ALHC) President Sells 27,243 Shares of Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) President Dawn Christine Maroney sold 27,243 shares of the company’s stock in a transaction on Wednesday, March 12th. The shares were sold at an average price of $15.43, for a total transaction of $420,359.49. Following the sale, the president now directly owns 2,276,732 shares in the company, valued at approximately $35,129,974.76. The trade was a 1.18 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Dawn Christine Maroney also recently made the following trade(s):

• On Thursday, March 6th, Dawn Christine Maroney sold 278,917 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.53, for a total transaction of $4,331,581.01.
• On Tuesday, February 18th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.72, for a total transaction of $411,600.00.
• On Wednesday, January 15th, Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $13.61, for a total transaction of $408,300.00.

Alignment Healthcare Stock Down 1.3 %

Alignment Healthcare stock traded down $0.21 during midday trading on Thursday, hitting $15.50. 1,216,078 shares of the company’s stock were exchanged, compared to its average volume of 2,088,706. The company has a debt-to-equity ratio of 1.82, a quick ratio of 1.60 and a current ratio of 1.60. Alignment Healthcare, Inc. has a 12 month low of $4.46 and a 12 month high of $16.25. The firm has a 50-day moving average of $14.22 and a two-hundred day moving average of $12.34. The company has a market cap of $2.97 billion, a PE ratio of -20.13 and a beta of 1.49.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ALHC. JPMorgan Chase & Co. boosted their price objective on shares of Alignment Healthcare from $14.00 to $17.00 and gave the company a “neutral” rating in a research report on Thursday, March 6th. William Blair reiterated an “outperform” rating on shares of Alignment Healthcare in a research report on Friday, February 28th. Bank of America boosted their price objective on shares of Alignment Healthcare from $15.50 to $18.50 and gave the company a “buy” rating in a research report on Tuesday, March 4th. Barclays upped their price target on shares of Alignment Healthcare from $8.00 to $9.00 and gave the stock an “underweight” rating in a report on Friday, February 28th. Finally, Stifel Nicolaus upped their price target on shares of Alignment Healthcare from $16.00 to $18.00 and gave the stock a “buy” rating in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, three have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $14.83.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ALHC. Wellington Management Group LLP grew its holdings in Alignment Healthcare by 77.9% during the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock worth $83,683,000 after acquiring an additional 3,257,630 shares in the last quarter. T. Rowe Price Investment Management Inc. lifted its position in shares of Alignment Healthcare by 54.7% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 8,649,042 shares of the company’s stock valued at $97,302,000 after buying an additional 3,059,596 shares during the last quarter. Millennium Management LLC lifted its position in shares of Alignment Healthcare by 588.3% during the fourth quarter. Millennium Management LLC now owns 3,388,602 shares of the company’s stock valued at $38,122,000 after buying an additional 2,896,311 shares during the last quarter. Point72 Asset Management L.P. purchased a new stake in shares of Alignment Healthcare during the fourth quarter valued at about $20,087,000. Finally, Broad Bay Capital Management LP purchased a new stake in shares of Alignment Healthcare during the fourth quarter valued at about $18,804,000. 86.19% of the stock is currently owned by institutional investors.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.